Last reviewed · How we verify

Sodium monofluorophosphate dentifrice

Procter and Gamble · FDA-approved active Small molecule

Sodium monofluorophosphate releases fluoride ions in the oral cavity to strengthen tooth enamel and inhibit bacterial acid production, preventing dental caries.

Sodium monofluorophosphate releases fluoride ions in the oral cavity to strengthen tooth enamel and inhibit bacterial acid production, preventing dental caries. Used for Dental caries prevention, Tooth enamel strengthening.

At a glance

Generic nameSodium monofluorophosphate dentifrice
SponsorProcter and Gamble
Drug classFluoride dentifrice
TargetTooth enamel hydroxyapatite; bacterial enolase
ModalitySmall molecule
Therapeutic areaDental/Oral Health
PhaseFDA-approved

Mechanism of action

Fluoride ions are incorporated into the hydroxyapatite crystal structure of tooth enamel, making it more resistant to demineralization by acids produced by cariogenic bacteria. Additionally, fluoride inhibits enolase in bacterial glycolytic pathways, reducing acid production and bacterial adhesion. This dual mechanism provides both remineralization and antimicrobial benefits for cavity prevention.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results